Salvaging the oral treatment failure patient

Current Sexual Health Reports

Volumn 3, Issue 1, 2006, Pages 20-24

  Pescatori, Edoardo S ^a   Drei, Barbara ^b   Morgia, Giuseppe ^b   Farina, Furio Pirozzi ^b  

^a HESPERIA HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL; VASOACTIVE AGENT;

ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FOLLOW UP; FOOD INTAKE; HUMAN; MALE GENITAL SYSTEM SURGERY; MEDICAL PRACTICE; PATIENT COMPLIANCE; RISK FACTOR; SELF INJECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33750293533     PISSN: 15483584     EISSN: 15483592     Source Type: Journal    
DOI: 10.1007/s11930-006-0022-6     Document Type: Article

References (23)

1. Padma-Nathan H, Christ G, Adaikan G, et al.: Pharmacotherapy for erectile dysfunction. In Sexual Medicine. Edited by Lue TF, Basson R, Rosen R, et al. Paris: Health Publication Ltd; 2004:503-566.
2. Lue TF, Basson R, Giuliano F: Summary of the Recommendations on Sexual Dysfunctions in Men. In Sexual Medicine. Edited by Lue TF, Basson R, Rosen R, et al. Paris: Health Publication Ltd; 2004:605-627. This chapter provides state-of-the-art recommendations in the diagnosis and treatment of ED. The whole process of interacting with the ED patient is quickly summarized in pages that represent extremely valuable reading for those that want an authoritative update on ED treatment.
3. Jardin A, Wagner G, Khoury S, et al.: Erectile Dysfunction. Plymouth, UK: Health Publication Ltd; 2000.
4. Fink HA, Mac Donald R, Rutks R, et al.: Sildenafil for male erectile dysfunction. Arch Intern Med 2002, 162:1349-1360.
5. Souverein PC, Egberts AC, Meuleman EJ, et al.: Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users. Int J Impot Res 2002, 14:259-265.
6. McCullough AR, Barada JH, Fawzy A, et al.: Achieving treatment optimization with sildenafil citrate (Viagra®) in patients with erectile dysfunction. Urology 2002, 60(Suppl 2):28-38. This paper is a landmark in optimization of oral treatment. At the time this paper was written, sildenafil was only just available. However, the recommendations included here are also substantially the same for the newcomer PDE5i drugs.
7. Hatzichristou D, Moysidis K, Apostolidis A, et al.: Sildenafil failures may be due to inadequate patient instructions and follow-up: a study on 100 non-responders. Eur Urol 2005, 47:518-523. A very recent paper outlining the most frequent pitfalls of non-ED specialists and how to address them.
8. Christiansen E, Guirguis WR, Cox D, et al.: Long-term efficacy and safety of oral Viagra (sildenafil citrate) in men with erectile dysfunction and the effect of randomised treatment withdrawal. Int J Impot Res 2000, 12:177-182.
9. Pallas J, Levine SB, Althof SE, Risen CB: A study using Viagra in a mental health practice. J Sex Marital Ther 2000, 26:41-50.
10. Althof SE: Quality of life and erectile dysfunction. Urology 2002, 59:803-810.
11. Barada J: Successful salvage of sildenafil (Viagra) failures: benefits of patient education and rechallenge with sildenafil. Int J Impot Res 2001, 13(Suppl 4):S49.
12. Jiann BP, Yu CC, Su CC, Huang JK: Rechallenge prior sildenafil nonresponders. Int J Impot Res 2004, 16:64-68.
13. Montorsi F, Padma-Nathan H, Buvat J, et al., for the Vardenafil Study Group: Earliest time to onset of action leading to successful intercourse with vardenafil determined in at-home setting: a randomised, placebo-controlled trial. J Sex Med 2004, 1:168-178.
14. Heaton JP, Dean J, Sleep DJ: Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction. Int J Impot Res 2002, 14:61-64.
15. Virag R, Becher E, Carrier S, et al.: Local pharmacological treatment modalities. In Erectile Dysfunction. Edited by Jardin A, Wagner G, Khoury S, et al. Plymouth, UK: Health Publication Ltd; 2000:305-354.
16. Aversa A, Isidori AM, De Martino MU, et al.: Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol 2000, 53:517-522.
17. Guay AT, Perez JB, Jacobson J, Newton RA: Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001, 22:793-797.
18. Aversa A, Isidori AM, Greco EA, et al.: Hormonal supplementation and erectile dysfunction. Eur Urol 2004, 45:535-538.
19. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004, 172:658-663.
20. Lewis RB, Bennett CJ, Borkon WD, et al.: Patient and partner satisfaction with VIAGRA (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology 2001, 57:960-965.
21. The Process of Care Consensus Panel: The process of care model for evaluation and treatment of erectile dysfunction. Int J Impot Res 1999, 11:59-70.
22. Hatzichristou DG: Sildenafil citrate: lessons learned from 3 years of clinical experience. Int J Impot Res 2002, 14(Suppl 1):S43-S52.
23. Fawzy A: Practice patterns of primary care physicians in management of erectile dysfunction. Int J Impot Res 2000, 12(Suppl 3):B10.